In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2 studies while phase 3 clinical trial is under way, Indian Council of Medical Research (ICMR) chief Balram Bhargava said on Tuesday.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3hLstak
0 Comments:
Post a Comment